AlzChem Group AG (ACT) Q3 2020 Earnings Report
CH:ACT Q3 2020 EPS Results
- Actual EPS
- CHF 0.35
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- CHF 10.73
CH:ACT Q3 2020 Revenue Results
- Actual Revenue
- CHF 181.72M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +4.78%
Earnings Announcement Details
- Quarter
- Q3 2020
- Date
- 11/11/2020
- Time
- TBA
- Conference Call
- Wednesday, November 11, 2020
CH:ACT Upcoming Earnings
AlzChem Group AG's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:ACT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | ―- | 1.53 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 1.321.23 | 1.48 | -16.77% (-0.25) | |
| Jul 30, 2026 | 2026 (Q2) | 1.531.53 | 1.45 | 5.73% (+0.08) | |
| Apr 30, 2026 | 2026 (Q1) | 1.631.63 | 1.33 | 22.92% (+0.30) | |
| Feb 27, 2026 | 2025 (Q4) | 1.531.53 | 1.37 | 11.41% (+0.16) | |
| Oct 30, 2025 | 2025 (Q3) | 1.461.48 | 1.12 | 31.97% (+0.36) | |
| Jul 30, 2025 | 2025 (Q2) | 1.451.45 | 1.3 | 11.35% (+0.15) | |
| Apr 30, 2025 | 2025 (Q1) | ―1.33 | 1.11 | 20.00% (+0.22) | |
| Feb 28, 2025 | 2024 (Q4) | 1.081.37 | 1 | 37.33% (+0.37) | |
| Nov 07, 2024 | 2024 (Q3) | 1.12- | 0.78 | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
